SELENON
protein-codingselenoprotein N, the group of Selenoproteins|EF-hand domain containing
Gene summary
This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016]
- RSMD1
- MDRS1
- SEPN1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~18.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011271
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100100
Submitter: ClinGen
SEPN1 (SELENON) was reported in relation to autosomal recessive SELENON-related myopathy in 2002 (Ferreiro et al., PMID: 12192640). At least 16 unique variants (missense, nonsense, splicing, and frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 18 probands in 3 publications (PMID: 12192640, 16779558, 21670436). The mechanism of disease is homozygous loss of function. This gene-disease association is supported by animal models. In summary, SEPN1 (SELENON) is definitively associated with autosomal recessive SELENON-related myopathy.
Inheritance Pattern: AR
Disease ID:MONDO:0800341
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0009711
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019951
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011271
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011271
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019398
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Cardiac involvement has been described in some individuals
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SELENON variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript . Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 105 | 4 | 112 | ||
| missense | 11 | 198 | 7 | 5 | 221 | |
| nonsense | 10 | 9 | 1 | 20 | ||
| start loss | 6 | 4 | 10 | |||
| frameshift | 23 | 8 | 3 | 34 | ||
| splice donor/acceptor (+/-2bp) | 4 | 11 | 3 | 18 | ||
| Total | 43 | 43 | 208 | 112 | 9 | 415 |
Highest pathogenic variant AF is 0.000118239
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| Ensembl | ENSP00000355141.2 | 13 | MANE Select | |
| RefSeq | NP_065184.2 | 13 | Standard | |
| RefSeq | NP_996809.1 | 12 | Standard | |
| Ensembl | ENSP00000346109.5 | 12 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| selenon | Danio rerio | Structure: slow muscle cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Selenium Micronutrient Network
- Selenium Metabolism and Selenoproteins
Biological Process
- respiratory system process
- mitochondrion organization
- skeletal muscle satellite cell differentiation
- skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
- positive regulation of skeletal muscle cell proliferation
Molecular Function
- calcium ion binding
- protein binding
- oxidoreductase activity
Cellular Component
- endoplasmic reticulum membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000361547
- Coding exons
- 13
- Length
- 18047
- Individuals with no LoFs
- 124739
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 93
- Defined
- 124832
- p
- 0.000373
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.424 | 275 | 296 | 0.931 | 0.0000194 | 3803 |
| Missense (PolyPhen) | 77 | 83.602 | 0.92103 | 957 | ||
| Synonymous | -1.37 | 148 | 128 | 1.15 | 0.00000948 | 1196 |
| Loss of Function | 1.49 | 18 | 26.2 | 0.686 | 0.00000143 | 309 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00019 | rare |
| Latino/Admixed American | 0.00030 | 0.00029 | rare |
| Ashkenazi Jewish | 0.0014 | 0.0014 | notable |
| East Asian | 0.00031 | 0.00028 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00036 | 0.00035 | rare |
| South Asian | 0.00034 | 0.00033 | rare |
| Other | 0.00099 | 0.00099 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 2: Plays an important role in cell protection against oxidative stress and in the regulation of redox-related calcium homeostasis. Regulates the calcium level of the ER by protecting the calcium pump ATP2A2 against the oxidoreductase ERO1A-mediated oxidative damage. Within the ER, ERO1A activity increases the concentration of H(2)O(2), which attacks the luminal thiols in ATP2A2 and thus leads to cysteinyl sulfenic acid formation (-SOH) and SEPN1 reduces the SOH back to free thiol (- SH), thus restoring ATP2A2 activity (PubMed:25452428). Acts as a modulator of ryanodine receptor (RyR) activity: protects RyR from oxidation due to increased oxidative stress, or directly controls the RyR redox state, regulating the RyR-mediated calcium mobilization required for normal muscle development and differentiation (PubMed:19557870, PubMed:18713863). {ECO:0000269|PubMed:18713863, ECO:0000269|PubMed:19557870, ECO:0000269|PubMed:25452428}.;
- Disease
- DISEASE: Rigid spine muscular dystrophy 1 (RSMD1) [MIM:602771]: A neuromuscular disorder characterized by poor axial muscle strength, scoliosis and neck weakness, and a variable degree of spinal rigidity. Early ventilatory insufficiency can lead to death by respiratory failure. {ECO:0000269|PubMed:11528383, ECO:0000269|PubMed:12192640, ECO:0000269|PubMed:15122708, ECO:0000269|PubMed:15668457, ECO:0000269|PubMed:18713863, ECO:0000269|PubMed:19067361}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:16365872}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.202
Intolerance Scores
- RVIS EVS
- 0.62
- RVIS percentile EVS
- 83.42
Essentials
- Essential (gene trap)
- N